Literature DB >> 19142752

Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric indices.

Mehmet Davutoglu1, Mesut Ozkaya, Ekrem Guler, Mesut Garipardic, Halil Gursoy, Hamza Karabiber, Metin Kilinc.   

Abstract

BACKGROUND: The aim of this study was to investigate the relationships between plasma visfatin, insulin resistance, lipid profile and anthropometric measurements in obese children. SUBJECTS AND METHODS: Plasma levels of visfatin, insulin, glucose, lipid profile and anthropometric indices were determined in 30 obese children and compared with those in 30 age- and gender-matched non-obese children. Visfatin was measured with enzyme-linked immunosorbent assay and logarithmically transformed to log visfatin for parametric comparisons.
RESULTS: The obese group had significantly elevated plasma visfatin, fasting glucose and insulin and homeostasis model assessment (HOMA) values, as well as elevated lipid concentrations, compared with non-obese children. In the obese group log visfatin correlated positively with weight (p = 0.007), waist circumference (p = 0.007), hip circumference (p = 0.034), BMI (p = 0.005), insulin (p = 0.041) and HOMA (p = 0.044). No correlation was found between visfatin and lipid profile in obese children (p >0.05). Linear regression analysis revealed significant positive relationships between log visfatin and BMI (p = 0.005), insulin and BMI (p <0.001), and between HOMA and BMI (p <0.001) in the obese group but not in the control group. Multivariate regression analysis with log visfatin as a dependent variable showed that only BMI (p = 0.005) and bodyweight (p = 0.014) correlated positively with log visfatin in obese children.
CONCLUSIONS: An increased visfatin concentration may be associated with BMI and insulin resistance in obese children. Although these findings may lay a foundation for further hypotheses, the limited sample size in the present study means that longitudinal studies with more patients are needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19142752     DOI: smw-12400

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  12 in total

1.  Plasma and myocardial visfatin expression changes are associated with therapeutic hypothermia protection during murine hemorrhagic shock/resuscitation.

Authors:  David G Beiser; Huashan Wang; Jing Li; Xu Wang; Violeta Yordanova; Anshuman Das; Tamara Mirzapoiazova; Joe G N Garcia; Susan A Stern; Terry L Vanden Hoek
Journal:  Resuscitation       Date:  2010-03-26       Impact factor: 5.262

2.  Inflammation, a link between obesity and cardiovascular disease.

Authors:  Zhaoxia Wang; Tomohiro Nakayama
Journal:  Mediators Inflamm       Date:  2010-08-05       Impact factor: 4.711

3.  Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients.

Authors:  Sahar Hossam El-Hini; Faten Ismail Mohamed; Amel Ali Hassan; Fatma Ali; Amel Mahmoud; Hanaa M Ibraheem
Journal:  Rheumatol Int       Date:  2013-03-08       Impact factor: 2.631

4.  The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity.

Authors:  V A Belo; M R Luizon; R Lacchini; J A Miranda; C M M Lanna; D C Souza-Costa; J E Tanus-Santos
Journal:  Int J Obes (Lond)       Date:  2013-09-12       Impact factor: 5.095

5.  The relationship between visfatin and serum concentrations of C-reactive protein, interleukin 6 in patients with metabolic syndrome.

Authors:  M J Hosseinzadeh-Attar; A Golpaie; M Foroughi; F Hosseinpanah; S Zahediasl; F Azizi
Journal:  J Endocrinol Invest       Date:  2016-03-29       Impact factor: 4.256

6.  Effects of low-glycemic index diet on plasma adipokines in obese children.

Authors:  Chonnikant Visuthranukul; Cameron Hurst; Sirinuch Chomtho
Journal:  Pediatr Res       Date:  2021-03-22       Impact factor: 3.756

7.  Serum visfatin levels, adiposity and glucose metabolism in obese adolescents.

Authors:  Derya Taşkesen; Birgül Kirel; Tercan Us
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-06

8.  Relationship between Serum Visfatin and Vascular Inflammation Markers Level in Beta Thalassemia Major Patients.

Authors:  Elham Hashemi Dehkordi; Seyed Mohammad Kazem Nourbakhsh; Noushin Rostampour; Fateme Alizadeh Boroujeni
Journal:  Int J Prev Med       Date:  2014-10

9.  Adipokines Vaspin and Visfatin in Obese Children.

Authors:  Hassan M Salama; Ashraf Galal; Ayat A Motawie; Ashraf F Kamel; Doaa M Ibrahim; Azza A Aly; Emman A Hassan
Journal:  Open Access Maced J Med Sci       Date:  2015-11-26

10.  eNAMPT Is Localised to Areas of Cartilage Damage in Patients with Hip Osteoarthritis and Promotes Cartilage Catabolism and Inflammation.

Authors:  Ashleigh M Philp; Sam Butterworth; Edward T Davis; Simon W Jones
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.